Annual CFO
-$10.83 M
+$17.51 M+61.79%
December 1, 2023
Summary
- As of February 8, 2025, QNTM annual cash flow from operations is -$10.83 million, with the most recent change of +$17.51 million (+61.79%) on December 1, 2023.
- During the last 3 years, QNTM annual CFO has risen by +$8.30 million (+43.40%).
- QNTM annual CFO is now -10827200.00% below its all-time high of -$100.00, reached on August 1, 2015.
Performance
QNTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$3.46 M
-$2.85 M-470.62%
September 1, 2024
Summary
- As of February 8, 2025, QNTM quarterly cash flow from operations is -$3.46 million, with the most recent change of -$2.85 million (-470.62%) on September 1, 2024.
- Over the past year, QNTM quarterly CFO has stayed the same.
- QNTM quarterly CFO is now -138332.00% below its all-time high of -$2500.00, reached on November 1, 2016.
Performance
QNTM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$6.89 M
-$1.75 M-33.98%
September 1, 2024
Summary
- As of February 8, 2025, QNTM TTM cash flow from operations is -$6.89 million, with the most recent change of -$1.75 million (-33.98%) on September 1, 2024.
- Over the past year, QNTM TTM CFO has stayed the same.
- QNTM TTM CFO is now -275596.00% below its all-time high of -$2500.00, reached on November 1, 2016.
Performance
QNTM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
QNTM Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +61.8% | 0.0% | 0.0% |
3 y3 years | +43.4% | +24.6% | +67.8% |
5 y5 years | +20.2% | +7.0% | +51.7% |
QNTM Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +61.8% | -470.6% | +63.2% | -34.0% | +75.7% |
5 y | 5-year | at high | +61.8% | -470.6% | +63.2% | -34.0% | +75.7% |
alltime | all time | <-9999.0% | +61.8% | <-9999.0% | +63.2% | <-9999.0% | +75.7% |
Quantum BioPharma Ltd Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$3.46 M(+470.6%) | -$6.89 M(+34.0%) |
Jun 2024 | - | -$606.50 K(-69.3%) | -$5.14 M(-36.1%) |
Mar 2024 | - | -$1.97 M(+131.7%) | -$8.05 M(-25.7%) |
Dec 2023 | -$10.83 M(-61.8%) | -$851.70 K(-50.3%) | -$10.83 M(-33.6%) |
Sep 2023 | - | -$1.71 M(-51.2%) | -$16.30 M(-26.3%) |
Jun 2023 | - | -$3.51 M(-26.2%) | -$22.10 M(-21.0%) |
Mar 2023 | - | -$4.75 M(-24.8%) | -$27.99 M(-1.2%) |
Dec 2022 | -$28.33 M(+36.6%) | -$6.33 M(-15.8%) | -$28.33 M(+8.6%) |
Sep 2022 | - | -$7.52 M(-20.0%) | -$26.10 M(+12.6%) |
Jun 2022 | - | -$9.40 M(+84.5%) | -$23.17 M(+13.8%) |
Mar 2022 | - | -$5.09 M(+24.5%) | -$20.36 M(-1.9%) |
Dec 2021 | -$20.75 M(+8.4%) | -$4.09 M(-10.8%) | -$20.75 M(-3.2%) |
Sep 2021 | - | -$4.59 M(-30.3%) | -$21.43 M(-2.5%) |
Jun 2021 | - | -$6.58 M(+20.0%) | -$21.98 M(+15.0%) |
Mar 2021 | - | -$5.48 M(+15.0%) | -$19.12 M(-0.1%) |
Dec 2020 | -$19.13 M | -$4.77 M(-7.2%) | -$19.13 M(+10.5%) |
Sep 2020 | - | -$5.14 M(+38.2%) | -$17.31 M(+21.3%) |
Jun 2020 | - | -$3.72 M(-32.2%) | -$14.27 M(-11.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2020 | - | -$5.49 M(+86.2%) | -$16.21 M(+18.2%) |
Dec 2019 | -$13.71 M(+1.0%) | -$2.95 M(+40.2%) | -$13.71 M(+3.5%) |
Sep 2019 | - | -$2.10 M(-62.8%) | -$13.25 M(-30.0%) |
Jun 2019 | - | -$5.66 M(+88.6%) | -$18.95 M(+24.3%) |
Mar 2019 | - | -$3.00 M(+20.5%) | -$15.24 M(+11.9%) |
Dec 2018 | -$13.58 M(>+9900.0%) | -$2.49 M(-68.1%) | -$13.62 M(+22.3%) |
Sep 2018 | - | -$7.80 M(+299.7%) | -$11.14 M(+233.2%) |
Jun 2018 | - | -$1.95 M(+46.0%) | -$3.34 M(+139.2%) |
Mar 2018 | - | -$1.34 M(+2660.5%) | -$1.40 M(+2186.7%) |
Feb 2018 | - | -$48.40 K(+1208.1%) | -$61.10 K(+174.0%) |
Dec 2017 | -$119.20 K(+464.9%) | - | - |
Nov 2017 | - | -$3700.00(+5.7%) | -$22.30 K(+5.7%) |
Aug 2017 | -$21.10 K(-22.4%) | -$3500.00(-36.4%) | -$21.10 K(+19.9%) |
May 2017 | - | -$5500.00(-42.7%) | -$17.60 K(+45.5%) |
Feb 2017 | - | -$9600.00(+284.0%) | -$12.10 K(+384.0%) |
Nov 2016 | - | -$2500.00 | -$2500.00 |
Aug 2016 | -$27.20 K(>+9900.0%) | - | - |
Aug 2015 | -$100.00 | - | - |
FAQ
- What is Quantum BioPharma Ltd annual cash flow from operations?
- What is the all time high annual CFO for Quantum BioPharma Ltd?
- What is Quantum BioPharma Ltd annual CFO year-on-year change?
- What is Quantum BioPharma Ltd quarterly cash flow from operations?
- What is the all time high quarterly CFO for Quantum BioPharma Ltd?
- What is Quantum BioPharma Ltd quarterly CFO year-on-year change?
- What is Quantum BioPharma Ltd TTM cash flow from operations?
- What is the all time high TTM CFO for Quantum BioPharma Ltd?
- What is Quantum BioPharma Ltd TTM CFO year-on-year change?
What is Quantum BioPharma Ltd annual cash flow from operations?
The current annual CFO of QNTM is -$10.83 M
What is the all time high annual CFO for Quantum BioPharma Ltd?
Quantum BioPharma Ltd all-time high annual cash flow from operations is -$100.00
What is Quantum BioPharma Ltd annual CFO year-on-year change?
Over the past year, QNTM annual cash flow from operations has changed by +$17.51 M (+61.79%)
What is Quantum BioPharma Ltd quarterly cash flow from operations?
The current quarterly CFO of QNTM is -$3.46 M
What is the all time high quarterly CFO for Quantum BioPharma Ltd?
Quantum BioPharma Ltd all-time high quarterly cash flow from operations is -$2500.00
What is Quantum BioPharma Ltd quarterly CFO year-on-year change?
Over the past year, QNTM quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Quantum BioPharma Ltd TTM cash flow from operations?
The current TTM CFO of QNTM is -$6.89 M
What is the all time high TTM CFO for Quantum BioPharma Ltd?
Quantum BioPharma Ltd all-time high TTM cash flow from operations is -$2500.00
What is Quantum BioPharma Ltd TTM CFO year-on-year change?
Over the past year, QNTM TTM cash flow from operations has changed by $0.00 (0.00%)